Pediatric Immunization

Latest News

Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study
Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study

May 2nd 2024

In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).

GSK Announces FDA PDUFA Date for 5-in-1 Meningococcal Vaccine / image credit GSK vaccines: ©desertsands/stock.adobe.com
GSK Announces FDA PDUFA Date for 5-in-1 Meningococcal Vaccine Based on Acceptance of BLA

April 17th 2024

Would you Know Measles if You Saw It?
Would you Know Measles if You Saw It?

March 18th 2024

Measles and the Collective American Memory: 3 Questions / image credit MMR vial:  ©Sherry Yates Young/Shutterstock.com
Measles and the Collective American Memory: 3 Questions

March 18th 2024

Nirsevimab 90% Effective Against RSV Hospitalization among Infants: Daily Dose / image credit: ©New Africa/AdobeStock
Nirsevimab Effective Against RSV Hospitalization among Infants: Daily Dose

March 18th 2024

Latest CME Events & Activities

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

3rd Annual International Congress on Pediatric Oncology

October 25, 2024

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

View More

Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Community Practice Connections™: Navigating a New Era of Food Allergy Management

View More

More News

© 2024 MJH Life Sciences

All rights reserved.